TABLE 3.
Variables | Univariable model | Multivariable model | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p‐value | HR | 95% CI | p‐value | ||
Training set (n = 246) | |||||||
GILncSig | High/low | 1.037 | 1.019–1.055 | <0.001 | 1.033 | 1.015–1.051 | <0.001 |
Age | >65/<=65 | 1.001 | 0.981–1.022 | 0.906 | |||
Gender | Male/female | 1.268 | 0.826–1.946 | 0.277 | |||
Stage | (III+IV)/(I+II) | 1.816 | 1.473–2.239 | <0.001 | 1.778 | 1.439–2.197 | <0.001 |
Testing set (n = 244) | |||||||
GILncSig | High/low | 1.073 | 1.019–1.128 | 0.007 | 1.057 | 1.004–1.112 | 0.034 |
Age | >65/<=65 | 1.007 | 0.984–1.031 | 0.544 | |||
Gender | Male/female | 0.941 | 0.616–1.439 | 0.780 | |||
Stage | (III+IV)/(I+II) | 1.500 | 1.238–1.817 | <0.001 | 1.481 | 1.219–1.799 | <0.001 |
TCGA set (n = 490) | |||||||
GILncSig | High/low | 1.029 | 1.019–1.039 | <0.001 | 1.026 | 1.016–1.036 | <0.001 |
Age | >65/<=65 | 1.005 | 0.989–1.020 | 0.553 | |||
Gender | Male/female | 1.113 | 0.825–1.500 | 0.484 | |||
Stage | (III+IV)/(I+II) | 1.641 | 1.425–1.890 | <0.001 | 1.623 | 1.408–1.871 | <0.001 |